Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis.
Wagner T, Shweta F, Murugadoss K, Awasthi S, Venkatakrishnan AJ, Bade S, Puranik A, Kang M, Pickering BW, O'Horo JC, Bauer PR, Razonable RR, Vergidis P, Temesgen Z, Rizza S, Mahmood M, Wilson WR, Challener D, Anand P, Liebers M, Doctor Z, Silvert E, Solomon H, Anand A, Barve R, Gores G, Williams AW, Morice WG 2nd, Halamka J, Badley A, Soundararajan V. Wagner T, et al. Among authors: badley a. Elife. 2020 Jul 7;9:e58227. doi: 10.7554/eLife.58227. Elife. 2020. PMID: 32633720 Free PMC article.
First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia.
Temesgen Z, Assi M, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Varatharaj Palraj BR, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley A. Temesgen Z, et al. Among authors: badley a. medRxiv [Preprint]. 2020 Jun 14:2020.06.08.20125369. doi: 10.1101/2020.06.08.20125369. medRxiv. 2020. Update in: Mayo Clin Proc. 2020 Nov;95(11):2382-2394. doi: 10.1016/j.mayocp.2020.08.038 PMID: 32587983 Free PMC article. Updated. Preprint.
Association of Intravenous Bamlanivimab Use with Reduced Hospitalization, Intensive Care Unit Admission, and Mortality in Patients with Mild to Moderate COVID-19.
Ganesh R, Pawlowski C, O'Horo JC, Arndt LL, Arndt R, Bell SJ, Bierle DM, Borgen MD, Hanson SN, Heyliger A, Larsen JJ, Lenehan P, Orenstein R, Puranik A, Speicher LL, Tulledge-Scheitel SM, Venkatakrishnan AJ, Wilker CG, Badley AD, Razonable RR. Ganesh R, et al. Among authors: badley ad. medRxiv [Preprint]. 2021 May 25:2021.05.23.21257670. doi: 10.1101/2021.05.23.21257670. medRxiv. 2021. Update in: J Clin Invest. 2021 Oct 1;131(19):e151697. doi: 10.1172/JCI151697 PMID: 34075387 Free PMC article. Updated. Preprint.
Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence.
Puranik A, Lenehan PJ, Silvert E, Niesen MJM, Corchado-Garcia J, O'Horo JC, Virk A, Swift MD, Halamka J, Badley AD, Venkatakrishnan AJ, Soundararajan V. Puranik A, et al. Among authors: badley ad. medRxiv [Preprint]. 2021 Aug 21:2021.08.06.21261707. doi: 10.1101/2021.08.06.21261707. medRxiv. 2021. PMID: 34401884 Free PMC article. Preprint.
Pro Inflammatory Cytokines Profiles of Patients With Long COVID Differ Between Variant Epochs.
Ganesh R, Yadav S, Hurt RT, Mueller MR, Aakre CA, Gilman EA, Grach SL, Overgaard J, Snyder MR, Collins NM, Croghan IT, Badley AD, Razonable RR, Salonen BR. Ganesh R, et al. Among authors: badley ad. J Prim Care Community Health. 2024 Jan-Dec;15:21501319241254751. doi: 10.1177/21501319241254751. J Prim Care Community Health. 2024. PMID: 38808863 Free PMC article.
Leveraging real-time patient data during the COVID-19 pandemic.
O'Horo JC, Challener DW, Kudrna C, Buckmeier JR, Peters SG, Kor DJ, Matson MW, Badley AD, Burger CD, Chaudhry R. O'Horo JC, et al. Among authors: badley ad. Infect Control Hosp Epidemiol. 2024 Oct 8:1-2. doi: 10.1017/ice.2024.118. Online ahead of print. Infect Control Hosp Epidemiol. 2024. PMID: 39376200 No abstract available.
LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL.
Temesgen Z, Burger CD, Baker J, Polk C, Libertin C, Kelley C, Marconi VC, Orenstein R, Durrant C, Chappell D, Ahmed O, Chappell G, Badley AD. Temesgen Z, et al. medRxiv [Preprint]. 2021 May 5:2021.05.01.21256470. doi: 10.1101/2021.05.01.21256470. medRxiv. 2021. PMID: 33972949 Free PMC article. Preprint.
Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening Strategies.
Xie Z, Saliba AN, Abeykoon J, Majeed U, Almquist DR, Wiedmeier-Nutor JE, Bezerra E, Andrade-Gonzalez X, Hickman A, Sorenson K, Rakshit S, Wee C, Tella SH, Kommalapati A, Abdallah N, Pritchett J, De Andrade M, Uprety D, Badley A, Manochakian R, Ailawadhi S, Bryce AH, Hubbard JM, Gangat N, Thompson CA, Witzig TE, McWilliams RR, Leventakos K, Halfdanarson TR. Xie Z, et al. Among authors: badley a. JCO Oncol Pract. 2021 Sep;17(9):e1382-e1393. doi: 10.1200/OP.21.00177. Epub 2021 Jun 14. JCO Oncol Pract. 2021. PMID: 34125579 Free PMC article.
C reactive protein utilisation, a biomarker for early COVID-19 treatment, improves lenzilumab efficacy: results from the randomised phase 3 'LIVE-AIR' trial.
Temesgen Z, Kelley CF, Cerasoli F, Kilcoyne A, Chappell D, Durrant C, Ahmed O, Chappell G, Catterson V, Polk C, Badley A, Marconi VC; LIVE-AIR Study Group. Temesgen Z, et al. Among authors: badley a. Thorax. 2023 Jun;78(6):606-616. doi: 10.1136/thoraxjnl-2022-218744. Epub 2022 Jul 6. Thorax. 2023. PMID: 35793833 Free PMC article. Clinical Trial.
218 results